BP says that any class member who wants to opt out has to provide certain information, such as identifying any American depositary share transactions during the class period. Read more
It’s believed this settlement is likely among the last major payments Pfizer will make over the two drugs. Read more
A New York federal judge has given final approval to a $55 million settlement by Intercept Pharmaceuticals Inc. Read more
If the settlement gets final approval, which is expected, RBS will pay $255 million and Goldman Sachs will pay $134 million. Read more
The result is an opinion that strings together broad statements about the ERISA duties. Read more
Several prominent universities have all been hit with claims under the Employee Retirement Income Security Act (ERISA) recently. Read more
A New Jersey federal judge has granted final approval to the $1.06 billion settlement between Merck & Co. Inc. and the drug company’s investors to resolve multidistrict litigation (MDL)... Read more
BP has agreed to pay $175 million to settle claims by U.S. investors that its managers lied about the size of the 2010 Gulf of Mexico oil spill. Read more
The proposed class includes those who purchased Intercept stock during two days that month. Read more
The court finds the settlement and plan of allocation to be fair, adequate, and reasonable to the settlement class and therefore is granting final approval. Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.